Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 36,144 | 4,822 | 2,440 | 1,911 | 648 |
| Gross Profit | 36,144 | 4,822 | 2,440 | 1,911 | 648 |
| Operating Expenses | 113,248 | 61,570 | 35,003 | 21,897 | 9,502 |
| Operating Income | -77,105 | -56,748 | -32,563 | -19,985 | -8,854 |
| Other Income | 5,651 | 1,076 | 141 | -14 | 3 |
| Pre-tax Income | -71,454 | -55,672 | -32,422 | -19,999 | -8,851 |
| Net Income Continuous | -71,454 | -55,672 | -32,422 | -19,999 | -8,851 |
| Net Income | $-71,454 | $-55,672 | $-32,422 | $-19,999 | $-8,851 |
| EPS Basic Total Ops | -33.63 | -29.43 | -19.52 | -14.71 | -8.41 |
| EPS Basic Continuous Ops | -33.58 | -29.33 | -19.40 | -14.60 | -8.48 |
| EPS Diluted Total Ops | -33.63 | -29.43 | -19.52 | -14.71 | -8.41 |
| EPS Diluted Continuous Ops | -33.58 | -29.33 | -19.40 | -14.60 | -8.48 |
| EPS Diluted Before Non-Recurring Items | -33.63 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-75,875 | $-56,254 | $-32,307 | $-19,897 | $-8,810 |